Analysis of the TGF beta functional pathway in epithelial ovarian carcinoma

Citation
Km. Francis-thickpenny et al., Analysis of the TGF beta functional pathway in epithelial ovarian carcinoma, BR J CANC, 85(5), 2001, pp. 687-691
Citations number
35
Categorie Soggetti
Oncology,"Onconogenesis & Cancer Research
Journal title
BRITISH JOURNAL OF CANCER
ISSN journal
00070920 → ACNP
Volume
85
Issue
5
Year of publication
2001
Pages
687 - 691
Database
ISI
SICI code
0007-0920(20010901)85:5<687:AOTTBF>2.0.ZU;2-2
Abstract
Epithelial ovarian carcinoma is often diagnosed at an advanced stage of dis ease and is the leading cause of death from gynaecological neoplasia. The g enetic changes that occur during the development of this carcinoma are poor ly understood. It has been proposed that IGFIIR, TGF beta1 and TGF beta RII act as a functional unit in the TGF beta growth inhibitory pathway, and th at somatic loss-of-function mutations in any one of these genes could lead to disruption of the pathway and subsequent loss of cell cycle control. We have examined these 3 genes in 25 epithelial ovarian carcinomas using singl e-stranded conformational polymorphism analysis and DNA sequence analysis. A total of 3 somatic missense mutations were found in the TGF beta RII gene , but none in IGFRII or TGF beta1. An association was found between TGF bet a RII mutations and histology, with 2 out of 3 clear cell carcinomas having TGF beta RII mutations. This data supports other evidence from mutational analysis of the PTEN and beta -catenin genes that there are distinct develo pmental pathways responsible for the progression of different epithelial ov arian cancer histologic subtypes. (C) 2001 Cancer Research Campaign.